Oral liquid l-thyroxine (l-T4) may be better absorbed compared to l-T4 tablets following bariatric surgery

Obesity Surgery

Volumn 23, Issue 9, 2013, Pages 1493-1496

  Pirola, Ilenia ^a   Formenti, Anna M ^a   Gandossi, Elena ^a   Mittempergher, Francesco ^b   Casella, Claudio ^b   Agosti, Barbara ^c   Cappelli, Carlo ^a  

^a SPEDALI CIVILI   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c Diabetes Unit   (Italy)

Author keywords

Absorption; l thyroxine; Liquid formulation; Roux en Y gastric bypass surgery; Severe obesity

Indexed keywords

LEVOTHYROXINE; LIOTHYRONINE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; BARIATRIC SURGERY; BODY MASS; CASE REPORT; CAUCASIAN; DRUG ABSORPTION; DRUG DOSAGE FORM COMPARISON; EUTHYROIDISM; FEMALE; HASHIMOTO DISEASE; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROIDISM; LIOTHYRONINE BLOOD LEVEL; PATIENT ATTITUDE; PRIORITY JOURNAL; ROUX Y ANASTOMOSIS; TABLET FORMULATION; THYROIDECTOMY; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TOXIC GOITER; TREATMENT RESPONSE; WEIGHT REDUCTION;

ADULT; FEMALE; GASTRIC BYPASS; HUMANS; MALABSORPTION SYNDROMES; MIDDLE AGED; OBESITY, MORBID; SUSPENSIONS; TABLETS; THERAPEUTIC EQUIVALENCY; THYROTROPIN; THYROXINE; TREATMENT OUTCOME;

EID: 84881144537     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-013-1015-y     Document Type: Article

References (21)

1. Samuel I, Mason EE, Renquist KE, Huang YH, et al. Bariatric surgery trends: an 18-year report from the International Bariatric Surgery Registry. Am J Surg. 2006;192(5):657-62. (Pubitemid 44634341)
2. Miller AD, Smith KM. Medication and nutrient administration considerations after bariatric surgery. Am J Health Syst Pharm. 2006;63(19):1852-7. (Pubitemid 44477456)
3. Padwal R, Brocks D, Sharma AM. A systematic review of drug absorption following bariatric surgery and its theoretical implications. Obes Rev. 2010;11(1):41-50.
4. Pacini F, Castagna MG. Approach to and treatment of differentiated thyroid carcinoma. Med Clin N Am. 2012;96(2):369-83.
5. Almandoz JP, Gharib H. Hypothyroidism: etiology, diagnosis, and management. Med Clin N Am. 2012;96(2):203-21.
6. Rubio IG, Galrão AL, Santo MA, et al. Levothyroxine absorption in morbidly obese patients before and after Roux-En-Y gastric bypass (RYGB) surgery. Obes Surg. 2012;22(2):253-8.
7. Centanni M, Gargano L, Canettieri G, et al. Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis. N Engl J Med. 2006;354(17):1787-95.
8. Checchi S, Montanaro A, Pasqui L, Ciuoli C, De Palo V, et al. l-thyroxine requirement in patients with autoimmune hypothyroidism and parietal cell antibodies. J Clin Endocrinol Metab. 2008;93(2):465-9. (Pubitemid 351240817)
9. Azizi F, Belur R, Albano J. Malabsorption of thyroid hormones after jejunoileal bypass for obesity. Ann Intern Med. 1979;90(6):941-2. (Pubitemid 9229632)
10. Bevan JS, Munro JF. Thyroxine malabsorption following intestinal bypass surgery. Int J Obes. 1986;10(3):245-6. (Pubitemid 16048560)
11. Benvenga S, Bartolone L, Squadrito S, et al. Delayed intestinal absorption of levothyroxine. Thyroid. 1995;5(4):249-53.
12. Lamson MJ, Pamplin CL, Rolleri RL, et al. Quantitation of a substantial reduction in levothyroxine (T4) absorption by food. Thyroid. 2004;14:876. abstract.
13. Benvenga S, Bartolone L, Pappalardo MA, et al. Altered intestinal absorption of l-thyroxine caused by coffee. Thyroid. 2008;18(3):293-301. (Pubitemid 351415797)
14. Liel Y, Sperber AD, Shany S. Nonspecific intestinal adsorption of levothyroxine by aluminum hydroxide. Am J Med. 1994;97(4):363-5. (Pubitemid 24313096)
15. Sherman SI, Tielens ET, Ladenson PW. Sucralfate causes malabsorption of l-thyroxine. Am J Med. 1994;96(6):531-5. (Pubitemid 24184438)
16. Campbell NR, Hasinoff BB, Stalts H, et al. Ferrous sulfate reduces thyroxine efficacy in patients with hypothyroidism. Ann Intern Med. 1992;117(12):1010-3.
17. Northcutt RC, Stiel JN, Hollifield JW, et al. The influence of cholestyramine on thyroxine absorption. J Am Med Assoc. 1969;208(10):1857-61.
18. Singh N, Weisler SL, Hershman JM. The acute effect of calcium carbonate on the intestinal absorption of levothyroxine. Thyroid. 2001;11(10):967-71. (Pubitemid 33020185)
19. Chiu AC, Sherman SI. Effects of pharmacological fiber supplements on levothyroxine absorption. Thyroid. 1998;8(8):667-71. (Pubitemid 28405153)
20. Saraceno G, Vita R, Trimarchi F, et al. A liquid formulation of l-thyroxine (l-T4) solves problems of incomplete normalization/suppression of serum TSH caused by proton pump inhibitors (PPI) on conventional tablet formulations of l-T4. Presented at European Society of Endocrinology ICE/ECE 2012 Florence, Italy. Endocrine Abstracts 29:P1626 [abstract].
21. Zhang H, Zhang J, Streisand JB. Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications. Clin Pharmacokinet. 2002;41(9):661-80.